Evan R Daugharthy

USPTO Granted Patents = 24 (Patent Applications = 22)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 3.6

ph-index = 12

Forward Citations = 836(Granted Patents)

Company Filing History:

Massachusetts Institute of Technology

4. 2 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331347 - Methods for high-throughput labelling and detection of biological features in situ using microscopy (2025-06-17),

2. 12264358 - Method of selectively sequencing amplicons in a biological sample (2025-04-01),

3. 12203136 - Methods and systems for spatial mapping of genetic variants (2025-01-21),

4. 12098425 - Three-dimensional spatial molecular indexing (2024-09-24),

5. 11718874 - Hybridization chain reaction methods for in situ molecular detection (2023-08-08),

6. 11713485 - Hybridization chain reaction methods for in situ molecular detection (2023-08-01),

7. 11697839 - Methods for detecting and identifying genomic nucleic acids (2023-07-11),

8. 11542554 - Method and apparatus for volumetric imaging (2023-01-03),

9. 11447807 - Methods of combining the detection of biomolecules into a single assay using fluorescent in situ sequencing (2022-09-20),

10. 11299767 - Method for generating a three-dimensional nucleic acid containing matrix (2022-04-12),

11. 11193163 - Methods and systems for sample processing or analysis (2021-12-07),

12. 11118220 - Method and apparatus for volumetric imaging of a three-dimensional nucleic acid containing matrix (2021-09-14),

13. 11111521 - Compositions and methods for analyte detection (2021-09-07),

14. 11085072 - Methods of generating libraries of nucleic acid sequences for detection via fluorescent in situ sequencing (2021-08-10),

15. 11078520 - Method for generating a three-dimensional nucleic acid containing matrix (2021-08-03),

Title: Evan R Daugharthy: Innovator in Molecular Biology

Introduction

Evan R Daugharthy is a prominent inventor based in Cambridge, MA, renowned for his significant contributions to molecular biology and genetics. With a total of 22 patents to his name, Daugharthy has been instrumental in developing advanced methodologies that enhance our understanding of genetic variants.

Latest Patents

Among his latest patented innovations are two groundbreaking technologies. The first, titled "Methods and systems for spatial mapping of genetic variants," provides comprehensive methodologies for analyzing biological samples from subjects. This process uses specific probes to accurately identify and determine the locations of various genetic sequences within a sample.

The second innovation is "Three-dimensional spatial molecular indexing," which outlines methods for generating and utilizing indices within a synthetic three-dimensional (3D) matrix from biological samples. This patent describes a meticulous process that incorporates the use of a transposase to insert a nucleic acid index sequence into nucleic acid molecules, allowing for the detection of their 3D spatial positions and enabling further analysis.

Career Highlights

Evan Daugharthy has had a distinguished career, holding influential positions at prestigious institutions such as Harvard University and the Massachusetts Institute of Technology (MIT). His work has elevated the standards of research and innovation in the biological sciences, particularly in the mapping and indexing of genetic materials.

Collaborations

Throughout his career, Daugharthy has collaborated with esteemed colleagues, including notable figures such as George M. Church and Richard C. Terry. These partnerships have not only facilitated groundbreaking research but have also contributed to the advancement of technologies that play a critical role in genetic analysis and molecular biology.

Conclusion

Evan R Daugharthy's contributions to the field of molecular biology through his inventive solutions and collaborative efforts underscore his importance as an innovator. His 22 patents reflect a dedication to advancing genetic research and analysis, paving the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.